Micro- and nanotechnologies for intracellular delivery.

The majority of drugs and biomolecules need to be delivered into cells to be effective. However, the cell membranes, a biological barrier, strictly resist drugs or biomolecules entering cells, resulting in significantly reduced intracellular delivery efficiency. To overcome this barrier, a variety of intracellular delivery approaches including chemical and physical ways have been developed in recent years. In this review, the focus is on summarizing the nanomaterial routes involved in making use of a collection of receptors for the targeted delivery of drugs and biomolecules and the physical ways of applying micro- and nanotechnologies for high-throughput intracellular delivery.

[1]  Julien Villemejane,et al.  Physical methods of nucleic acid transfer: general concepts and applications , 2009, British journal of pharmacology.

[2]  Na Zhang,et al.  Tumor specific delivery and therapy by double-targeted nanostructured lipid carriers with anti-VEGFR-2 antibody. , 2011, Molecular pharmaceutics.

[3]  S. Baker,et al.  Tumor targeting by covalent conjugation of a natural fatty acid to paclitaxel. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[4]  K. Mølhave,et al.  Fibroblasts Cultured on Nanowires Exhibit Low Motility, Impaired Cell Division, and DNA Damage , 2013, Small.

[5]  Harvey T. McMahon,et al.  Molecular mechanism and physiological functions of clathrin-mediated endocytosis , 2011, Nature Reviews Molecular Cell Biology.

[6]  R. Rachel,et al.  Layer-by-layer coated gold nanoparticles: size-dependent delivery of DNA into cells. , 2012, Small.

[7]  T. Ogihara,et al.  Transfection of NFκB-decoy oligodeoxynucleotides using efficient ultrasound-mediated gene transfer into donor kidneys prolonged survival of rat renal allografts , 2003, Gene Therapy.

[8]  N. Yang,et al.  In vivo and in vitro gene transfer to mammalian somatic cells by particle bombardment. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[9]  N. Yang,et al.  Gene gun-mediated skin transfection with interleukin 12 gene results in regression of established primary and metastatic murine tumors. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[10]  Jill P. Mesirov,et al.  Targeted Tumor-Penetrating siRNA Nanocomplexes for Credentialing the Ovarian Cancer Oncogene ID4 , 2012, Science Translational Medicine.

[11]  Dexiang Chen,et al.  Improved DNA vaccination by skin-targeted delivery using dry-coated densely-packed microprojection arrays. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[12]  Hsin‐Lung Chen,et al.  The use of biodegradable polymeric nanoparticles in combination with a low-pressure gene gun for transdermal DNA delivery. , 2008, Biomaterials.

[13]  Natalia Vykhodtseva,et al.  Targeted delivery of doxorubicin to the rat brain at therapeutic levels using MRI‐guided focused ultrasound , 2007, International journal of cancer.

[14]  X. Jing,et al.  A Polymer–(Tandem Drugs) Conjugate for Enhanced Cancer Treatment , 2013, Advanced healthcare materials.

[15]  Zhuang Liu,et al.  Carrier-free, functionalized drug nanoparticles for targeted drug delivery. , 2012, Chemical communications.

[16]  Chih-Kuang Yeh,et al.  Concurrent blood-brain barrier opening and local drug delivery using drug-carrying microbubbles and focused ultrasound for brain glioma treatment. , 2012, Biomaterials.

[17]  Richard Leapman,et al.  Flower-like Au-Fe3O4 optical nanosensor for imaging protease expressions in vivo , 2011, 2011 IEEE/NIH Life Science Systems and Applications Workshop (LiSSA).

[18]  Wei Li,et al.  Water-dispersible, pH-stable and highly-luminescent organic dye nanoparticles with amplified emissions for in vitro and in vivo bioimaging. , 2014, Small.

[19]  R. Mumper,et al.  Oil‐Filled Lipid Nanoparticles Containing 2′‐(2‐Bromohexadecanoyl)‐Docetaxel for the Treatment of Breast Cancer , 2013, Advanced healthcare materials.

[20]  Daniel Anderson,et al.  Delivery materials for siRNA therapeutics. , 2013, Nature materials.

[21]  W. Arap,et al.  The neovasculature homing motif NGR: more than meets the eye. , 2008, Blood.

[22]  Weihong Tan,et al.  DNA aptamer-mediated cell targeting. , 2013, Angewandte Chemie.

[23]  Chi‐Kuang Sun,et al.  Quantitative and qualitative investigation into the impact of focused ultrasound with microbubbles on the triggered release of nanoparticles from vasculature in mouse tumors. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[24]  B. Cui,et al.  Intracellular Recording of Action Potentials by Nanopillar Electroporation , 2012, Nature nanotechnology.

[25]  S. Lummis,et al.  Biolistic transfection of neuronal cultures using a hand-held gene gun , 2006, Nature Protocols.

[26]  Mark R. Prausnitz,et al.  Dissolving Polymer Microneedle Patches for Influenza Vaccination , 2010, Nature Medicine.

[27]  Shi Xu,et al.  Targeting receptor-mediated endocytotic pathways with nanoparticles: rationale and advances. , 2013, Advanced drug delivery reviews.

[28]  E. Neumann,et al.  Gene transfer into mouse lyoma cells by electroporation in high electric fields. , 1982, The EMBO journal.

[29]  C. Finch,et al.  The physiology of transferrin and transferrin receptors. , 1987, Physiological reviews.

[30]  K. Parang,et al.  Cell-penetrating homochiral cyclic peptides as nuclear-targeting molecular transporters. , 2011, Angewandte Chemie.

[31]  Ning Wang,et al.  Mechanochemical delivery and dynamic tracking of fluorescent quantum dots in the cytoplasm and nucleus of living cells. , 2009, Nano letters.

[32]  S. Schwarze,et al.  In vivo protein transduction: delivery of a biologically active protein into the mouse. , 1999, Science.

[33]  Thierry Bettinger,et al.  Plasma membrane poration induced by ultrasound exposure: implication for drug delivery. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[34]  J. Connor,et al.  Receptor for interleukin 13 is a marker and therapeutic target for human high-grade gliomas. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[35]  Ryuichi Morishita,et al.  An efficient gene transfer method mediated by ultrasound and microbubbles into the kidney , 2005, The journal of gene medicine.

[36]  Mark E. Davis,et al.  Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles , 2010, Nature.

[37]  S. Ganta,et al.  A review of stimuli-responsive nanocarriers for drug and gene delivery. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[38]  Ick Chan Kwon,et al.  Self-assembled hyaluronic acid nanoparticles for active tumor targeting. , 2010, Biomaterials.

[39]  Miu Shan Chan,et al.  Nanoneedle-assisted delivery of site-selective peptide-functionalized DNA nanocages for targeting mitochondria and nuclei. , 2014, Small.

[40]  Lu Wang,et al.  Two-order targeted brain tumor imaging by using an optical/paramagnetic nanoprobe across the blood brain barrier. , 2012, ACS nano.

[41]  Jian-hui Jiang,et al.  Aptamer-modified nanodrug delivery systems. , 2011, ACS nano.

[42]  Li Tang,et al.  Aptamer-functionalized, ultra-small, monodisperse silica nanoconjugates for targeted dual-modal imaging of lymph nodes with metastatic tumors. , 2012, Angewandte Chemie.

[43]  G. Lin,et al.  Controllable drug release and simultaneously carrier decomposition of SiO2-drug composite nanoparticles. , 2013, Journal of the American Chemical Society.

[44]  G. Morelli,et al.  Peptide-based targeting strategies for simultaneous imaging and therapy with nanovectors , 2013 .

[45]  Leone Spiccia,et al.  Nanomaterials: Applications in Cancer Imaging and Therapy , 2011, Advanced materials.

[46]  S. González-Chávez,et al.  Lactoferrin: structure, function and applications. , 2009, International journal of antimicrobial agents.

[47]  Irwin Hollander,et al.  Gemtuzumab ozogamicin, a potent and selective anti-CD33 antibody-calicheamicin conjugate for treatment of acute myeloid leukemia. , 2002, Bioconjugate chemistry.

[48]  Simon Benita,et al.  Antibody conjugated PLGA nanoparticles for targeted delivery of paclitaxel palmitate: efficacy and biofate in a lung cancer mouse model. , 2013, Small.

[49]  Joseph Park,et al.  Anchored proteinase-targetable optomagnetic nanoprobes for molecular imaging of invasive cancer cells. , 2012, Angewandte Chemie.

[50]  Bo Zhang,et al.  Acid-active cell-penetrating peptides for in vivo tumor-targeted drug delivery. , 2013, Journal of the American Chemical Society.

[51]  Ick Chan Kwon,et al.  A near-infrared-fluorescence-quenched gold-nanoparticle imaging probe for in vivo drug screening and protease activity determination. , 2008, Angewandte Chemie.

[52]  Biofunctionalized targeted nanoparticles for therapeutic applications , 2008 .

[53]  Justin H Lo,et al.  Identification and Characterization of Receptor-Specific Peptides for siRNA Delivery , 2012, ACS nano.

[54]  M Halliwell,et al.  Sonoporation, drug delivery, and gene therapy , 2010, Proceedings of the Institution of Mechanical Engineers. Part H, Journal of engineering in medicine.

[55]  Mark E. Davis,et al.  Nanoparticle therapeutics: an emerging treatment modality for cancer , 2008, Nature Reviews Drug Discovery.

[56]  Angelo Paradiso,et al.  The complexity of targeting EGFR signalling in cancer: from expression to turnover. , 2006, Biochimica et biophysica acta.

[57]  H. McMahon,et al.  Mechanisms of endocytosis. , 2009, Annual review of biochemistry.

[58]  M. Bretscher Endocytosis: relation to capping and cell locomotion. , 1984, Science.

[59]  Y. Taniyama,et al.  Development of safe and efficient novel nonviral gene transfer using ultrasound: enhancement of transfection efficiency of naked plasmid DNA in skeletal muscle , 2002, Gene Therapy.

[60]  Yongjun Wang,et al.  The holistic 3M modality of drug delivery nanosystems for cancer therapy. , 2013, Nanoscale.

[61]  A. Hoffman,et al.  Target specific and long-acting delivery of protein, peptide, and nucleotide therapeutics using hyaluronic acid derivatives. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[62]  P. Chu,et al.  Nanoparticles for Improving Cancer Diagnosis. , 2013, Materials science & engineering. R, Reports : a review journal.

[63]  Peidong Yang,et al.  Interfacing silicon nanowires with mammalian cells. , 2007, Journal of the American Chemical Society.

[64]  Douglas L. Miller,et al.  Transfection of a reporter plasmid into cultured cells by sonoporation in vitro. , 1997, Ultrasound in medicine & biology.

[65]  Zhuang Liu,et al.  Carrier-free functionalized multidrug nanorods for synergistic cancer therapy. , 2013, Biomaterials.

[66]  Mariangela Spitali,et al.  Therapeutic antibody fragments with prolonged in vivo half-lives , 1999, Nature Biotechnology.

[67]  Hua Ai,et al.  Applications and potential toxicity of magnetic iron oxide nanoparticles. , 2013, Small.

[68]  Byung-Heon Lee,et al.  Phage display selection of peptides that home to atherosclerotic plaques: IL-4 receptor as a candidate target in atherosclerosis , 2008, Journal of cellular and molecular medicine.

[69]  C. Chuang,et al.  Cooperative dual-activity targeted nanomedicine for specific and effective prostate cancer therapy. , 2012, ACS nano.

[70]  G. Anderson,et al.  Docosahexaenoic Acid Is the Preferred Dietary n-3 Fatty Acid for the Development of the Brain and Retina , 1990, Pediatric Research.

[71]  R. Zhuo,et al.  Theranostic GO-based nanohybrid for tumor induced imaging and potential combinational tumor therapy. , 2014, Small.

[72]  Victor Frenkel,et al.  Ultrasound mediated delivery of drugs and genes to solid tumors. , 2008, Advanced drug delivery reviews.

[73]  Dong Sun,et al.  Reorganization of cytoskeleton and transient activation of Ca2+ channels in mesenchymal stem cells cultured on silicon nanowire arrays. , 2013, ACS applied materials & interfaces.

[74]  Xiaogang Liu,et al.  NIR photoresponsive crosslinked upconverting nanocarriers toward selective intracellular drug release. , 2013, Small.

[75]  Shuming Nie,et al.  Single chain epidermal growth factor receptor antibody conjugated nanoparticles for in vivo tumor targeting and imaging. , 2008, Small.

[76]  J. Fries,et al.  Specific occlusion of murine and human tumor vasculature by VCAM-1-targeted recombinant fusion proteins. , 2005, Journal of the National Cancer Institute.

[77]  A. Taketo DNA transfection of Escherichia coli by electroporation. , 1988, Biochimica et biophysica acta.

[78]  Yu Chen,et al.  Nuclear-targeted drug delivery of TAT peptide-conjugated monodisperse mesoporous silica nanoparticles. , 2012, Journal of the American Chemical Society.

[79]  Yang Guo,et al.  Irreversible electroporation therapy in the liver: longitudinal efficacy studies in a rat model of hepatocellular carcinoma. , 2010, Cancer research.

[80]  Raffi Bekeredjian,et al.  Ultrasound-Targeted Microbubble Destruction Can Repeatedly Direct Highly Specific Plasmid Expression to the Heart , 2003, Circulation.

[81]  Hong Xu,et al.  Active targeting using HER-2-affibody-conjugated nanoparticles enabled sensitive and specific imaging of orthotopic HER-2 positive ovarian tumors. , 2014, Small.

[82]  T. V. van Berkel,et al.  Recombinant lipoproteins: lipoprotein-like lipid particles for drug targeting. , 2001, Advanced drug delivery reviews.

[83]  Kullervo Hynynen,et al.  Ultrasound for drug and gene delivery to the brain. , 2008, Advanced drug delivery reviews.

[84]  Xihui Gao,et al.  Nanoprobes visualizing gliomas by crossing the blood brain tumor barrier. , 2014, Small.

[85]  A. P. Chapman,et al.  PEGylated antibodies and antibody fragments for improved therapy: a review. , 2002, Advanced drug delivery reviews.

[86]  P. Low,et al.  Folate receptor-targeted drugs for cancer and inflammatory diseases. , 2004, Advanced drug delivery reviews.

[87]  R. Tsien,et al.  Activatable cell penetrating peptides linked to nanoparticles as dual probes for in vivo fluorescence and MR imaging of proteases , 2010, Proceedings of the National Academy of Sciences.

[88]  R. Ladner,et al.  Phage display-derived peptides as therapeutic alternatives to antibodies. , 2004, Drug discovery today.

[89]  R. W. Davis,et al.  Inhibition of gene expression in plant cells by expression of antisense RNA. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[90]  A. Ullrich,et al.  The discovery of receptor tyrosine kinases: targets for cancer therapy , 2004, Nature Reviews Cancer.

[91]  J. Brugge,et al.  Integrins and signal transduction pathways: the road taken. , 1995, Science.

[92]  S. Tsutsui,et al.  Prognostic value of epidermal growth factor receptor (EGFR) and its relationship to the estrogen receptor status in 1029 patients with breast cancer , 2004, Breast Cancer Research and Treatment.

[93]  H. Ohno,et al.  Detection of small differences in the hydrophilicity of ions using the LCST-type phase transition of an ionic liquid-water mixture. , 2013, Chemical communications.

[94]  Yuhong Cao,et al.  Nanostraw-electroporation system for highly efficient intracellular delivery and transfection. , 2013, ACS nano.

[95]  Ryuichi Morishita,et al.  Local Delivery of Plasmid DNA Into Rat Carotid Artery Using Ultrasound , 2002, Circulation.

[96]  H. Aihara,et al.  Gene transfer into muscle by electroporation in vivo , 1998, Nature Biotechnology.

[97]  Robert Langer,et al.  Transdermal drug delivery , 2008, Nature Biotechnology.

[98]  L. Gold,et al.  Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. , 1990, Science.

[99]  Julie H. Campbell,et al.  Antibody‐Targeted Drug Delivery to Injured Arteries Using Layered Double Hydroxide Nanoparticles , 2012, Advanced healthcare materials.

[100]  Philip S Low,et al.  Discovery and development of folic-acid-based receptor targeting for imaging and therapy of cancer and inflammatory diseases. , 2008, Accounts of chemical research.

[101]  Fang Liu,et al.  Conjugation of Functionalized SPIONs with Transferrin for Targeting and Imaging Brain Glial Tumors in Rat Model , 2012, PloS one.

[102]  S. Nakagawa,et al.  Cancer gene therapy by IL-12 gene delivery using liposomal bubbles and tumoral ultrasound exposure. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[103]  Gyudo Lee,et al.  Real-time quantitative monitoring of specific peptide cleavage by a proteinase for cancer diagnosis. , 2012, Angewandte Chemie.

[104]  G. Bendas,et al.  VCAM-1 directed immunoliposomes selectively target tumor vasculature in vivo. , 2008, Biochimica et biophysica acta.

[105]  Astrid Gräslund,et al.  Efficient intracellular delivery of nucleic acid pharmaceuticals using cell-penetrating peptides. , 2012, Accounts of chemical research.

[106]  J. Lieberman,et al.  Special delivery: targeted therapy with small RNAs , 2011, Gene Therapy.

[107]  J. Gehl,et al.  Electroporation: theory and methods, perspectives for drug delivery, gene therapy and research. , 2003, Acta physiologica Scandinavica.

[108]  Jin Sun,et al.  Folate and CD44 receptors dual-targeting hydrophobized hyaluronic acid paclitaxel-loaded polymeric micelles for overcoming multidrug resistance and improving tumor distribution. , 2014, Journal of pharmaceutical sciences.

[109]  D. S. Lee,et al.  Stimulus‐Sensitive Polymeric Nanoparticles and Their Applications as Drug and Gene Carriers , 2013, Advanced healthcare materials.

[110]  I. Ojima,et al.  Recent advances in tumor-targeting anticancer drug conjugates. , 2005, Bioorganic & medicinal chemistry.

[111]  P. Swaan,et al.  Endocytic mechanisms for targeted drug delivery. , 2007, Advanced drug delivery reviews.

[112]  Manabu Kinoshita,et al.  Noninvasive localized delivery of Herceptin to the mouse brain by MRI-guided focused ultrasound-induced blood-brain barrier disruption. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[113]  C. Chiang,et al.  First demonstration of gold nanorods-mediated photodynamic therapeutic destruction of tumors via near infra-red light activation. , 2014, Small.

[114]  K. Plate,et al.  Up-regulation of flk-1/vascular endothelial growth factor receptor 2 by its ligand in a cerebral slice culture system. , 1997, Cancer research.

[115]  A. Borowsky,et al.  Cellular heterogeneity profiling by hyaluronan probes reveals an invasive but slow-growing breast tumor subset , 2014, Proceedings of the National Academy of Sciences.

[116]  Dongsheng Liu,et al.  Efficient, pH‐Triggered Drug Delivery Using a pH‐Responsive DNA‐Conjugated Gold Nanoparticle , 2013, Advanced healthcare materials.

[117]  R. Wirth,et al.  Transformation of bacteria with plasmid DNA by electroporation. , 1988, Analytical biochemistry.

[118]  Linlin Li,et al.  Mesoporous Silica Nanoparticles: Synthesis, Biocompatibility and Drug Delivery , 2012, Advanced materials.

[119]  A. Rajasekaran,et al.  Clinical trials of cancer therapies targeting prostate-specific membrane antigen. , 2007, Reviews on recent clinical trials.

[120]  P. Leder,et al.  Enhancer-dependent expression of human kappa immunoglobulin genes introduced into mouse pre-B lymphocytes by electroporation. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[121]  P. Couvreur,et al.  Nanocarriers’ entry into the cell: relevance to drug delivery , 2009, Cellular and Molecular Life Sciences.

[122]  Omid C Farokhzad,et al.  Aptamer-functionalized nanoparticles for medical applications: challenges and opportunities. , 2012, ACS nano.

[123]  T. Wu,et al.  DNA vaccines for cervical cancer: from bench to bedside , 2007, Experimental & Molecular Medicine.

[124]  S. Johnston,et al.  Introduction of foreign genes into tissues of living mice by DNA-coated microprojectiles. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[125]  Kwan Soo Hong,et al.  Targeted theranostic nanoparticles: receptor-mediated entry into cells, pH-induced signal generation and cytosolic delivery. , 2014, Small.

[126]  Ü. Langel,et al.  Cell-penetrating peptides: design, synthesis, and applications. , 2014, ACS nano.

[127]  Mingyuan Gao,et al.  Receptor-mediated delivery of magnetic nanoparticles across the blood-brain barrier. , 2012, ACS nano.

[128]  Y. Jeong,et al.  Image-guided prostate cancer therapy using aptamer-functionalized thermally cross-linked superparamagnetic iron oxide nanoparticles. , 2011, Small.

[129]  Jacob T. Robinson,et al.  Vertical silicon nanowires as a universal platform for delivering biomolecules into living cells , 2010, Proceedings of the National Academy of Sciences.

[130]  Yana K Reshetnyak,et al.  Family of pH (low) insertion peptides for tumor targeting , 2013, Proceedings of the National Academy of Sciences.

[131]  Z. Qian,et al.  Transferrin/transferrin receptor-mediated drug delivery. , 2002, Medicinal research reviews.

[132]  D. Engelman,et al.  pHLIP peptide targets nanogold particles to tumors , 2012, Proceedings of the National Academy of Sciences.

[133]  T. Budinger,et al.  Synthetic nano-LDL with paclitaxel oleate as a targeted drug delivery vehicle for glioblastoma multiforme. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[134]  V. Walbot,et al.  Expression of genes transferred into monocot and dicot plant cells by electroporation. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[135]  Xian‐Zheng Zhang,et al.  A dual-responsive mesoporous silica nanoparticle for tumor-triggered targeting drug delivery. , 2014, Small.

[136]  Bo Yu,et al.  Nanochannel electroporation delivers precise amounts of biomolecules into living cells. , 2011, Nature nanotechnology.

[137]  C. Tung,et al.  Enhancing the Cellular Delivery of Nanoparticles Using Lipo‐Oligoarginine Peptides , 2012, Advanced functional materials.

[138]  A. Lapillonne,et al.  The role of essential fatty acids in development. , 2005, Annual review of nutrition.

[139]  Joseph Irudayaraj,et al.  Nuclear targeting dynamics of gold nanoclusters for enhanced therapy of HER2+ breast cancer. , 2011, ACS nano.

[140]  R. Chari,et al.  Antibody-drug conjugates: an emerging concept in cancer therapy. , 2014, Angewandte Chemie.

[141]  Tarl W Prow,et al.  Nanocomposite‐Strengthened Dissolving Microneedles for Improved Transdermal Delivery to Human Skin , 2014, Advanced healthcare materials.

[142]  S. Piletsky,et al.  Engineered Magnetic Nanoparticles for Biomedical Applications , 2014, Advanced healthcare materials.

[143]  E. D. Wolf,et al.  High-velocity microprojectiles for delivering nucleic acids into living cells , 1987, Nature.

[144]  Chaoliang He,et al.  Stimuli‐Sensitive Synthetic Polypeptide‐Based Materials for Drug and Gene Delivery , 2012, Advanced healthcare materials.

[145]  M. Dewhirst,et al.  Effective tumor therapy with plasmid-encoded cytokines combined with in vivo electroporation. , 2001, Cancer research.

[146]  W. Fair,et al.  Molecular cloning of a complementary DNA encoding a prostate-specific membrane antigen. , 1993, Cancer research.

[147]  Tetsuichiro Saito In vivo electroporation in the embryonic mouse central nervous system , 2006, Nature Protocols.

[148]  K. Y. Zhang,et al.  A Diamond Nanoneedle Array for Potential High‐Throughput Intracellular Delivery , 2013, Advanced healthcare materials.

[149]  Simon C Watkins,et al.  Direct transfection and activation of human cutaneous dendritic cells , 2001, Gene Therapy.

[150]  Ick Chan Kwon,et al.  In vivo targeted delivery of nanoparticles for theranosis. , 2011, Accounts of chemical research.

[151]  K. Yeung,et al.  A diamond nanocone array for improved osteoblastic differentiation. , 2013, Journal of materials chemistry. B.

[152]  R. Guy,et al.  Physical methods for gene transfer: improving the kinetics of gene delivery into cells. , 2005, Advanced drug delivery reviews.

[153]  M. Brown,et al.  Degradation of cationized low density lipoprotein and regulation of cholesterol metabolism in homozygous familial hypercholesterolemia fibroblasts. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[154]  Gert Storm,et al.  Endosomal escape pathways for delivery of biologicals. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[155]  Préat,et al.  In vivo efficacy and safety of skin electroporation. , 1999, Advanced drug delivery reviews.

[156]  Napoleone Ferrara,et al.  Vascular Endothelial Growth Factor Signaling Pathways: Therapeutic Perspective , 2006, Clinical Cancer Research.

[157]  Ning Gu,et al.  Controlled release of Fe3O4 nanoparticles in encapsulated microbubbles to tumor cells via sonoporation and associated cellular bioeffects. , 2011, Small.

[158]  I. Ojima Guided molecular missiles for tumor-targeting chemotherapy--case studies using the second-generation taxoids as warheads. , 2008, Accounts of chemical research.

[159]  Yury Gogotsi,et al.  Multifunctional carbon-nanotube cellular endoscopes. , 2011, Nature nanotechnology.

[160]  T. Geng,et al.  Flow-through electroporation based on constant voltage for large-volume transfection of cells. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[161]  J F Greenleaf,et al.  Ultrasound-mediated transfection of mammalian cells. , 1996, Human gene therapy.

[162]  N. Melosh,et al.  Nanostraws for direct fluidic intracellular access. , 2012, Nano letters.

[163]  Jacob T. Robinson,et al.  Vertical nanowire electrode arrays as a scalable platform for intracellular interfacing to neuronal circuits. , 2012, Nature nanotechnology.

[164]  C. Cordon-Cardo,et al.  Prostate-specific membrane antigen expression in normal and malignant human tissues. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[165]  Y. Yarden,et al.  Untangling the ErbB signalling network , 2001, Nature Reviews Molecular Cell Biology.

[166]  L. Traub Tickets to ride: selecting cargo for clathrin-regulated internalization , 2009, Nature Reviews Molecular Cell Biology.

[167]  Yu Zhang,et al.  Lactoferrin-conjugated superparamagnetic iron oxide nanoparticles as a specific MRI contrast agent for detection of brain glioma in vivo. , 2011, Biomaterials.

[168]  Lisa Brannon-Peppas,et al.  Active targeting schemes for nanoparticle systems in cancer therapeutics. , 2008, Advanced drug delivery reviews.

[169]  K. Shroff,et al.  Peptide Targeted Lipid Nanoparticles for Anticancer Drug Delivery , 2012, Advanced materials.

[170]  B. Grant,et al.  Pathways and mechanisms of endocytic recycling , 2009, Nature Reviews Molecular Cell Biology.

[171]  R. Longhi,et al.  IsoDGR-tagged albumin: a new αvβ3 selective carrier for nanodrug delivery to tumors. , 2013, Small.

[172]  C. Bertozzi,et al.  A cell nanoinjector based on carbon nanotubes , 2007, Proceedings of the National Academy of Sciences.

[173]  S. Hui,et al.  Electroporation-enhanced gene delivery in mammary tumors , 2000, Gene Therapy.